Anti-tuberculosis treatment strategies and drug development: challenges and priorities
VA Dartois, EJ Rubin - Nature Reviews Microbiology, 2022 - nature.com
Despite two decades of intensified research to understand and cure tuberculosis disease,
biological uncertainties remain and hamper progress. However, owing to collaborative …
biological uncertainties remain and hamper progress. However, owing to collaborative …
Tuberculosis: pathogenesis, current treatment regimens and new drug targets
Mycobacterium tuberculosis (M. tb), the causative agent of TB, is a recalcitrant pathogen that
is rife around the world, latently infecting approximately a quarter of the worldwide …
is rife around the world, latently infecting approximately a quarter of the worldwide …
Tuberculosis drug discovery: challenges and new horizons
Over the past 2000 years, tuberculosis (TB) has claimed more lives than any other infectious
disease. In 2020 alone, TB was responsible for 1.5 million deaths worldwide, comparable to …
disease. In 2020 alone, TB was responsible for 1.5 million deaths worldwide, comparable to …
Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Heterogeneity in tuberculosis
Infection with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), results
in a range of clinical presentations in humans. Most infections manifest as a clinically …
in a range of clinical presentations in humans. Most infections manifest as a clinically …
[HTML][HTML] The antibiotic resistance crisis, with a focus on the United States
E Martens, AL Demain - The Journal of antibiotics, 2017 - nature.com
Beginning with the discovery of penicillin by Alexander Fleming in the late 1920s, antibiotics
have revolutionized the field of medicine. They have saved millions of lives each year …
have revolutionized the field of medicine. They have saved millions of lives each year …
[HTML][HTML] New agents for the treatment of drug-resistant Mycobacterium tuberculosis
DT Hoagland, J Liu, RB Lee, RE Lee - Advanced drug delivery reviews, 2016 - Elsevier
Inadequate dosing and incomplete treatment regimens, coupled with the ability of the
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen
A Maitra, T Munshi, J Healy, LT Martin… - FEMS microbiology …, 2019 - academic.oup.com
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis,
remains one of the leading causes of mortality across the world. There is an urgent …
remains one of the leading causes of mortality across the world. There is an urgent …
An overview of new antitubercular drugs, drug candidates, and their targets
A Bahuguna, DS Rawat - Medicinal research reviews, 2020 - Wiley Online Library
The causative agent of tuberculosis (TB), Mycobacterium tuberculosis and more recently
totally drug‐resistant strains of M. tuberculosis, display unique mechanisms to survive in the …
totally drug‐resistant strains of M. tuberculosis, display unique mechanisms to survive in the …
Metformin as adjunct antituberculosis therapy
The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential
new approach to TB therapy is to augment protective host immune responses. We report that …
new approach to TB therapy is to augment protective host immune responses. We report that …